Related Experiment Video
Updated: Oct 22, 2025
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
8.9K
A mechanism for localized dynamics-driven activation in Bruton's tyrosine kinase
Simei Qiu1,2, Yunfeng Liu1, Quhuan Li1,2
1Institute of Biomechanics/School of Bioscience and Bioengineering, South China University of Technology, Guangzhou People's Republic of China.
Royal Society Open Science
|August 30, 2021
Summary
New Bruton's tyrosine kinase (BTK) inhibitors are crucial for treating B-cell malignancies. Understanding BTK activation mechanisms, like the T474M mutation, is key to overcoming drug resistance and improving treatment efficacy.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Bruton's tyrosine kinase (BTK) is essential for B-cell development and function.
- BTK inhibitors are used to treat B-cell malignancies.
- Drug resistance and low efficacy necessitate new therapeutic strategies.
Purpose of the Study:
- Investigate the activation mechanism of BTK.
- Elucidate the molecular basis of drug resistance in BTK inhibitors.
- Identify potential targets for novel drug development.
Main Methods:
- Free molecular dynamics simulations were employed.
- The BTK T474M mutation was used as a resistance model.
- Conformational changes in the kinase domain were analyzed.
Main Results:
- The T474M mutation enhances BTK kinase activity.
- Conformational changes in the activation ring and ATP binding sites were observed.
- The Thr474 mutation stabilizes the ATP binding site via A-loop structural changes, boosting catalytic activity.
Conclusions:
- The study reveals a dynamics-driven activation and resistance mechanism in BTK.
- Findings offer insights into developing improved BTK inhibitors.
- This research may advance therapeutic strategies for B-cell malignancies.
Related Concept Videos
01:26Receptor Tyrosine Kinases
15.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.3K
01:22Amplifying Signals via Enzymatic Cascade
14.1K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.1K
01:00Enzyme-linked Receptors
80.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.9K
01:07MAPK Signaling Cascades
6.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.2K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.2K
01:15Activation of Integrins
4.0K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
4.0K